Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132435) titled 'Diagnostic Efficacy and Predictive Model Construction of Oral Gastrointestinal Ultrasound Contrast Agent Combined with Tumor Markers for Gastric Cancer Risk Based on Machine Learning Methods' on Sept. 14.

Study Type: Diagnostic test

Study Design: Sequential

Primary Sponsor: The First Hospital of Putian

Condition: Gastric Cancer

Intervention: Gold Standard:Histopathological examination (surgical or endoscopic biopsy pathological results). In cases where histopathological examination is unavailable, comprehensive clinical follow-up and imaging re-evaluation will be used as the reference standard.

Recruitme...